Skip to main content

Table 5 Odds ratios of conversion to total hip arthroplasty between treatment groups

From: Regenerative therapies for femoral head necrosis in the past two decades: a systematic review and network meta-analysis

ABG

2.88 (0.46, 20.88)

1.79 (0.24, 18.33)

9.42 (0.7, 297.19)

0.58 (0.09, 3.92)

2.25 (0.42, 10.57)

1.7 (0.07, 50.38)

 

ABG + BMAC

0.62 (0.04, 12.36)

3.25 (0.13, 166.78)

0.2 (0.01, 2.85)

0.78 (0.06, 8.23)

0.58 (0.01, 26.96)

  

BMAC

5.21 (0.83, 60.65)

0.32 (0.1, 0.74)

1.24 (0.09, 11.31)

0.94 (0.05, 15.9)

   

MSCs

0.06 (0.001, 0.4)

0.24 (0.01, 3.71)

0.18 (0, 4.65)

    

CD

3.83 (0.42, 31.95)

2.9 (0.22, 47.38)

     

FVBG

0.76 (0.03, 27.1

      

PRP

  1. ABG autologous bone grafting, ABG + BMAC autologous bone grafting and bone marrow aspirate concentrate, BMAC bone marrow aspirate concentration, CD core decompression, FVBG free vascular vascularized bone grafting, MSCs mesenchymal stem cells, PRP platelet-rich plasma
Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512